| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |